INFECTIOUS DISEASES I PANEL
Series Editors:
Reviewers
John E. Murphy, Pharm.D., FCCP, FASHP
Professor of Pharmacy Practice and Science
Associate Dean for Academic Affairs and Assessment
University of Arizona College of Pharmacy
Tucson, Arizona
Christopher R. Frei, Pharm.D., M.Sc., FCCP, BCPS
Associate Professor
Head, Division of Pharmacotherapy
The University of Texas at Austin College of Pharmacy
Austin, Texas
Adjoint Associate Professor
Director, Pharmacotherapy Education
and Research Center
University of Texas Health Science
Center School of Medicine
San Antonio, Texas
Mary Wun-Len Lee, Pharm.D., FCCP, BCPS
Vice President and Chief Academic Officer
Pharmacy and Health Sciences Education
Midwestern University
Professor of Pharmacy Practice
Midwestern University
Chicago College of Pharmacy
Downers Grove, Illinois
Faculty Panel Chair
Ian R. McNicholl, Pharm.D., FCCP,
BCPS (AQ-ID), AAHIVP
Associate Director, Medical Affairs
Gilead Sciences
Foster City, California
Skin and Soft Tissue Infections
Authors
Elias B. Chahine, Pharm.D., BCPS (AQ-ID)
Associate Professor of Pharmacy Practice
Department of Pharmacy Practice
Palm Beach Atlantic University
Lloyd L. Gregory School of Pharmacy
West Palm Beach, Florida
Clinical Pharmacist
Department of Pharmacy
JFK Medical Center
Atlantis, Florida
Allana J. Sucher, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Department of Pharmacy Practice
Regis University
Rueckert-Hartman College for Health Professions
Denver, Colorado
Eric Dietrich, Pharm.D., BCPS
Clinical Assistant Professor
Department of Pharmacotherapy and Translational
Research; Community Health and Family Medicine
University of Florida Colleges of
Pharmacy and Medicine
Gainesville, Florida
Intra-abdominal Infections
Author
David T. Bearden, Pharm.D.
Clinical Associate Professor and Chair
Department of Pharmacy Practice
Oregon State University College of Pharmacy
Portland, Oregon
Clinical Assistant Director
Department of Pharmacy Services
Oregon Health & Science University
Portland, Oregon
Reviewers
Wilson Ly, Pharm.D., BCPS, AAHIVP
HIV and Hepatitis C Clinical Pharmacist
Department of Santa Clara Valley Medical Center,
Partners In AIDS Care and Education (PACE) Clinic
Santa Clara Valley Medical Center
San Jose, California
Medical Student
Department of University of California San
Francisco School of Medicine and University of
California Berkeley School of Public Health
University of California San Francisco and
University of California Berkeley
San Francisco, California
Kathleen A. Lusk, Pharm.D., BCPS
Assistant Professor
Department of Pharmacy Practice
University of the Incarnate Word
Feik School of Pharmacy
Clinical Pharmacy Specialist
South Texas Veterans Health Care System
San Antonio, Texas
Bone and Joint Infections
Authors
Sandy J. Estrada, Pharm.D., BCPS (AQ-ID)
Clinical Specialist – Infectious Diseases
Lee Memorial Health System
Fort Myers, Florida
Reviewers
Scott Bergman, Pharm.D., BCPS (AQ-ID)
Associate Professor Department of Pharmacy Practice Southern Illinois University
Edwardsville School of Pharmacy
Edwardsville, Illinois
PGY2 Infectious Diseases Pharmacy
Residency Program Director
HSHS St. John’s Hospital
Springfield, Illinois
Shaun P. Keegan, Pharm.D, BCPS
Clinical Pharmacy Specialist, Critical Care
UC Health - University Hospital
Department of Pharmacy Services
Cincinnati, Ohio
The American College of Clinical Pharmacy and the
authors thank the following individuals for their careful
review of the Infectious Diseases I chapters:
Judy Cheng, Pharm.D., MPH, BCPS (AQ Cardiology)
Professor of Pharmacy Practice
Department of Pharmacy Practice
MCPHS University
Clinical Pharmacy Specialist
Department of Pharmacy
Brigham and Women’s Hospital
Boston, Massachusetts
Marisel Segarra-Newnham, Pharm.D.,
MPH, FCCP, BCPS
Clinical Pharmacy Specialist, Infectious Diseases
Pharmacy Service
Veterans Affairs Medical Center
West Palm Beach, Florida
Clinical Assistant Professor of Pharmacy Practice
University of Florida College of Pharmacy
Gainesville, Florida
Ralph H. Raasch, Pharm.D., BCPS
Associate Professor of Pharmacy (retired)
Division of Practice Advancement
and Clinical Education
Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Disclosure of Potential Conflicts of
Interest
Consultancies: Craig R. Ballard ( Janssen, ViiV Healthcare); Sandy Bartlett (Sunflower Developmental Solutions); David T.
Bearden (Society of Infectious Diseases Pharmacists); Chi Duong (Warm Springs Health & Wellness Center); Sandy J.
Estrada (Astellas); Monica V. Mahoney (Cubist Pharmaceuticals), (Forest Laboratories); Russell E. Lewis (Merck & Co.,
Inc.), (Gilead); Wilson O. Ly (Pacific AIDS Education Training Center); Christopher McCoy (Durata, Astra Zeneca);
Stock Ownership: Jennifer Cocohoba (Arena Pharmaceuticals [spouse or significant other]);
Royalties:
Grants: David T. Bearden (Cubist Pharmaceuticals); Elias B. Chahine (Cubist Pharmaceuticals, Inc.); Jennifer Cocohoba
(National Institutes of Mental Health); Christopher R. Frei (Bristol-Myers Squibb [2 grants], Forest, Pfizer); Katie J. Suda
(Intel Corporation); Christopher McCoy (Forest/Cerexa)
Honoraria: Craig R. Ballard ( Janssen, Gilead Sciences, Merck, ViiV Healthcare, Simply Speaking HIV); Scott J. Bergman
(Sanofi-Pasteur); P. Brandon Bookstaver (Merck and Co, Inc.); Elias B. Chahine (Cubist Pharmaceuticals, Inc., Forest
Pharmaceuticals, Inc., Optimer Pharmaceuticals, Inc.); Sandy J. Estrada (Cubist); Lucas Hill (International Antiviral
Society-USA); Vanthida Huang (Forest Pharmaceutical, Inc.); Wilson O. Ly (Gilead Sciences); Allana J. Sucher (AbbVie)
Other:
Nothing to Disclose: Matthew F. Ambury, Melissa Badowski, Kimberli M. Burgner, Jessica Cottreau, Paulina Deming, Eric
A. Dietrich, Nancy E. Flentge, Alexandria Garavaglia-Wilson, Taylor K. Gill, Shellee A. Grim, Carol Heunisch, Shaun
P. Keegan, Thomas J. Kleyn, Kristi M. Kuper, Becky S. Linn, Kim G. Luk, Kathleen A. Lusk, Michelle T. Martin, Kari
A. McCracken, Ian R. McNicholl, April Miller Quidley, Carolyn Orendorff, Michael Ott, Jennifer Phillips, Abby Rivas
Marrero, Amy N. Schilling, Douglas Slain, Inna S. Tsuker
ROLE OF BPS: The Board of Pharmacy Specialties (BPS) is an autonomous division of the American Pharmacists
Association (APhA). BPS is totally separate and distinct from ACCP. The Board, through its specialty councils, is
responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. PSAP has been approved by BPS for use in BCPS recertification. Information about the BPS recertification
process is available at www.bpsweb.org/recertification/general.cfm.
Other questions regarding recertification should be directed to:
Board of Pharmacy Specialties
2215 Constitution Avenue NW
Washington, DC 20037
(202) 429-7591
www.bpsweb.org
PSAP 2015 • Infectious Diseases
iv
Disclosure of Potential Conflicts of Interest